{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:39:06Z","timestamp":1761507546599,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Paediatric Respiratory Reviews"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.prrv.2023.07.001","type":"journal-article","created":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T21:29:31Z","timestamp":1689370171000},"page":"16-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Variable and evolving degrees of CFTR dysfunction: Implications for diagnosis and clinical management"],"prefix":"10.1016","volume":"47","author":[{"given":"A.","family":"Shawcross","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.C.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Pabary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prrv.2023.07.001_b0005","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jpeds.2016.09.064","article-title":"Diagnosis of cystic fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation","volume":"181","author":"Farrell","year":"2017","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.prrv.2023.07.001_b0010","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jcf.2018.02.006","article-title":"ECFS best practice guidelines: the 2018 revision","volume":"17","author":"Castellani","year":"2018","journal-title":"J Cyst Fibros"},{"issue":"4922","key":"10.1016\/j.prrv.2023.07.001_b0015","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.2475911","article-title":"Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA","volume":"245","author":"Riordan","year":"1989","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.prrv.2023.07.001_b0020","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S2213-2600(16)00023-0","article-title":"Progress in therapies for cystic fibrosis","volume":"4","author":"De Boeck","year":"2016","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.prrv.2023.07.001_b0025","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jcf.2008.09.005","article-title":"A European consensus for the evaluation and management of infants with an equivocal diagnosis following newborn screening for cystic fibrosis","volume":"8","author":"Mayell","year":"2009","journal-title":"J Cyst Fibros"},{"issue":"6","key":"10.1016\/j.prrv.2023.07.001_b0030","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jcf.2015.01.001","article-title":"Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID): A new designation and management recommendations for infants with an inconclusive diagnosis following newborn screening","volume":"14","author":"Munck","year":"2015","journal-title":"J Cyst Fibros"},{"issue":"6 Suppl","key":"10.1016\/j.prrv.2023.07.001_b0035","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1016\/j.jpeds.2009.09.003","article-title":"Cystic Fibrosis Foundation practice guidelines for the management of infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome during the first two years of life and beyond","volume":"155","author":"Borowitz","year":"2009","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.prrv.2023.07.001_b0040","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jcf.2020.11.006","article-title":"Updated guidance on the management of children with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome\/cystic fibrosis screen positive, inconclusive diagnosis (CRMS\/CFSPID)","volume":"20","author":"Barben","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"6","key":"10.1016\/j.prrv.2023.07.001_b0045","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jcf.2022.09.005","article-title":"ECFS standards of care on CFTR-related disorders: Diagnostic criteria of CFTR dysfunction","volume":"21","author":"Sermet-Gaudelus","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"6","key":"10.1016\/j.prrv.2023.07.001_b0050","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jcf.2022.09.011","article-title":"ECFS standards of care on CFTR-related disorders: Updated diagnostic criteria","volume":"21","author":"Castellani","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"7","key":"10.1016\/j.prrv.2023.07.001_b0055","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1002\/ppul.24819","article-title":"How to define CRMS\/CFSPID conversion to CF","volume":"55","author":"Rock","year":"2020","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"10.1016\/j.prrv.2023.07.001_b0060","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/j.jcf.2021.06.012","article-title":"When CFSPID becomes CF","volume":"21","author":"Ginsburg","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"25","key":"10.1016\/j.prrv.2023.07.001_b0065","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1056\/NEJM198112173052502","article-title":"Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis","volume":"305","author":"Knowles","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prrv.2023.07.001_b0070","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/978-1-61779-117-8_6","article-title":"Nasal potential difference measurements to assess CFTR ion channel activity","volume":"741","author":"Rowe","year":"2011","journal-title":"Methods Mol Biol"},{"issue":"6","key":"10.1016\/j.prrv.2023.07.001_b0075","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/thx.2009.123422","article-title":"Measurement of nasal potential difference in young children with an equivocal sweat test following newborn screening for cystic fibrosis","volume":"65","author":"Sermet-Gaudelus","year":"2010","journal-title":"Thorax"},{"issue":"10","key":"10.1016\/j.prrv.2023.07.001_b0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047708","article-title":"Measurements of CFTR-mediated Cl- secretion in human rectal biopsies constitute a robust biomarker for Cystic Fibrosis diagnosis and prognosis","volume":"7","author":"Sousa","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.prrv.2023.07.001_b0085","article-title":"Adolescent connectedness: cornerstone for health and wellbeing","volume":"379","author":"Blum","year":"2022","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.prrv.2023.07.001_b0090","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1177\/2374373520974322","article-title":"Virtual peer support for people with cystic fibrosis and their family members: A program evaluation","volume":"7","author":"Jeffrey","year":"2020","journal-title":"J Patient Exp"},{"issue":"Suppl 1","key":"10.1016\/j.prrv.2023.07.001_b0095","first-page":"29","article-title":"Severe pulmonary exacerbation in cystic fibrosis caused by cat allergy","volume":"15","author":"Pabary","year":"2014","journal-title":"Paediatr Respir Rev"},{"issue":"7","key":"10.1016\/j.prrv.2023.07.001_b0100","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.celrep.2019.01.068","article-title":"Rectal Organoids Enable Personalized Treatment of Cystic Fibrosis","volume":"26","author":"Berkers","year":"2019","journal-title":"Cell Rep"},{"issue":"6","key":"10.1016\/j.prrv.2023.07.001_b0105","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1186\/rr82","article-title":"'CFTR-opathies': disease phenotypes associated with cystic fibrosis transmembrane regulator gene mutations","volume":"2","author":"Noone","year":"2001","journal-title":"Respir Res"},{"key":"10.1016\/j.prrv.2023.07.001_b0110","doi-asserted-by":"crossref","unstructured":"Classification of cystic fibrosis and related disorders. J Cyst Fibros. 2002;1(1):5-8.","DOI":"10.1016\/S1569-1993(01)00007-8"},{"issue":"2","key":"10.1016\/j.prrv.2023.07.001_b0115","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/1099-0496(200008)30:2<139::AID-PPUL9>3.0.CO;2-H","article-title":"Time to think again: cystic fibrosis is not an \u201call or none\u201d disease","volume":"30","author":"Bush","year":"2000","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.prrv.2023.07.001_b0120","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2017.00390","article-title":"Personalized or precision medicine? The example of cystic fibrosis","volume":"8","author":"Marson","year":"2017","journal-title":"Front Pharmacol"}],"container-title":["Paediatric Respiratory Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526054223000416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526054223000416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:36:35Z","timestamp":1761507395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526054223000416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":24,"alternative-id":["S1526054223000416"],"URL":"https:\/\/doi.org\/10.1016\/j.prrv.2023.07.001","relation":{},"ISSN":["1526-0542"],"issn-type":[{"type":"print","value":"1526-0542"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Variable and evolving degrees of CFTR dysfunction: Implications for diagnosis and clinical management","name":"articletitle","label":"Article Title"},{"value":"Paediatric Respiratory Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prrv.2023.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}